PT-141 Peptide Therapy
Sexual Enhancement
Available in: Self-Injections and Nasal Spray
PT-141 offers several potential benefits.
Increased sexual desire and libido
Improved sexual arousal and performance
Improved erectile function
Enhanced orgasmic response
Improved emotional connection and intimacy
PT-141 (Bremelanotide) activates melanocortin receptors in the brain responsible for sexual desire and arousal. Because it targets the neural circuits behind libido rather than relying on vascular mechanisms, it addresses sexual dysfunction at its origin for both men and women.
PT-141 is available as both a subcutaneous injection and a nasal spray, with your provider determining the best format based on your health profile. It is one of the few peptide therapies that works for both men and women, and effects are typically felt within hours of administration.
PT-141 binds to MC3R and MC4R melanocortin receptors in the hypothalamus, the brain region that governs sexual response. This activates the neural pathways responsible for arousal and desire directly, bypassing the vascular approach used by PDE5 inhibitors. The result is increased libido and sexual readiness driven by central nervous system activation.
The services provided have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. The material on this website is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any treatment or therapy program. Any designations or references to therapies are for marketing purposes only and do not represent actual products.
